logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

LSL Pharma Group Inc. completes acquisition of Virage Santé to expand contract development and manufacturing activities

Jun 18, 2024•over 1 year ago

Acquiring Company

LSL Pharma Group

Acquired Company

Virage Santé

BouchervilleLévisManufacturingHealth CareManufacturing

Description

LSL Pharma Group Inc., a Canadian integrated pharmaceutical company, has successfully completed the acquisition of Virage Santé, a company specializing in the manufacturing and marketing of natural health products (NHPs) based in Lévis, Quebec. This acquisition will increase LSL Pharma's contract development and manufacturing activities, create synergies with its subsidiary LSL Laboratory Inc., and contribute to boosting LSL Pharma`s revenues by 15-20% annually, as well as broadening its client base.

Company Information

Company

LSL Pharma Group

Location

Boucherville, Quebec, Canada

About

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. . Leveraging its technical expertise, certified facilities, and experienced team, LSL Pharma delivers high-quality solutions that meet the highest industry standards. The companies that are part of the LSL Pharma Group are Steri-Med Pharma Inc., Laboratoire LSL Inc., Virage Santé Inc., Dermolab Pharma Ltd. and Laboratoire Du-Var Inc.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed